Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
Clinical trial NCT05739942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05739942
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2028-11-08
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.